Cargando…
Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor
BACKGROUND: Mesenchymal chondrosarcoma is an uncommon malignant variant of chondrosarcoma that mainly affects the bones and cartilaginous tissues, but may rarely involve the spine. Careful preoperative planning for surgical tumor removal and spine reconstruction is mandatory and must be based on onc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159291/ https://www.ncbi.nlm.nih.gov/pubmed/37151474 http://dx.doi.org/10.25259/SNI_206_2023 |
_version_ | 1785037106274369536 |
---|---|
author | Dehneh, Younes Aldabbas, Mohannad Elfarissi, Mohammed Alamine Khoulali, Mohamed Oulali, Noureddine Moufid, Faycel |
author_facet | Dehneh, Younes Aldabbas, Mohannad Elfarissi, Mohammed Alamine Khoulali, Mohamed Oulali, Noureddine Moufid, Faycel |
author_sort | Dehneh, Younes |
collection | PubMed |
description | BACKGROUND: Mesenchymal chondrosarcoma is an uncommon malignant variant of chondrosarcoma that mainly affects the bones and cartilaginous tissues, but may rarely involve the spine. Careful preoperative planning for surgical tumor removal and spine reconstruction is mandatory and must be based on oncologic and surgical staging. CASE DESCRIPTION: Over 1 month, a 16-year-old female became paraplegic with a T9 sensory level and urinary dysfunction. The magnetic resonance imaging revealed an intraspinal extradural T7-T9 mass that was isointense in T1W1 and markedly enhanced with gadolinium. The patient underwent gross-total tumor resection followed by an osteoplastic laminectomy with fusion. The histological examination was consistent with a mesenchymal chondrosarcoma. She had received radiation and chemotherapy. One year later, she was readmitted for tumor recurrence with multiple metastases involving L1, the lung, and peritoneum. Despite full course of radiotherapy and chemotherapy, she died after 6 months of the second surgery. CONCLUSION: Total resection of mesenchymal chondrosarcomas is the gold standard for treatment and is typically followed by radiation and/or chemotherapy. However, the status of residual tumor, local extension, and or metastases best determine the overall survival which may prove extremely limited. |
format | Online Article Text |
id | pubmed-10159291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-101592912023-05-05 Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor Dehneh, Younes Aldabbas, Mohannad Elfarissi, Mohammed Alamine Khoulali, Mohamed Oulali, Noureddine Moufid, Faycel Surg Neurol Int Case Report BACKGROUND: Mesenchymal chondrosarcoma is an uncommon malignant variant of chondrosarcoma that mainly affects the bones and cartilaginous tissues, but may rarely involve the spine. Careful preoperative planning for surgical tumor removal and spine reconstruction is mandatory and must be based on oncologic and surgical staging. CASE DESCRIPTION: Over 1 month, a 16-year-old female became paraplegic with a T9 sensory level and urinary dysfunction. The magnetic resonance imaging revealed an intraspinal extradural T7-T9 mass that was isointense in T1W1 and markedly enhanced with gadolinium. The patient underwent gross-total tumor resection followed by an osteoplastic laminectomy with fusion. The histological examination was consistent with a mesenchymal chondrosarcoma. She had received radiation and chemotherapy. One year later, she was readmitted for tumor recurrence with multiple metastases involving L1, the lung, and peritoneum. Despite full course of radiotherapy and chemotherapy, she died after 6 months of the second surgery. CONCLUSION: Total resection of mesenchymal chondrosarcomas is the gold standard for treatment and is typically followed by radiation and/or chemotherapy. However, the status of residual tumor, local extension, and or metastases best determine the overall survival which may prove extremely limited. Scientific Scholar 2023-04-07 /pmc/articles/PMC10159291/ /pubmed/37151474 http://dx.doi.org/10.25259/SNI_206_2023 Text en Copyright: © 2023 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Dehneh, Younes Aldabbas, Mohannad Elfarissi, Mohammed Alamine Khoulali, Mohamed Oulali, Noureddine Moufid, Faycel Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor |
title | Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor |
title_full | Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor |
title_fullStr | Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor |
title_full_unstemmed | Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor |
title_short | Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor |
title_sort | spinal mesenchymal chondrosarcoma: a case report of a rare malignant tumor |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159291/ https://www.ncbi.nlm.nih.gov/pubmed/37151474 http://dx.doi.org/10.25259/SNI_206_2023 |
work_keys_str_mv | AT dehnehyounes spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor AT aldabbasmohannad spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor AT elfarissimohammedalamine spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor AT khoulalimohamed spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor AT oulalinoureddine spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor AT moufidfaycel spinalmesenchymalchondrosarcomaacasereportofararemalignanttumor |